AzTrials
AzTrials

Heat StrokeNCT06537557

Application of an Early In-Hospital Temperature Management Protocol for Heat Stroke Patients

A study testing the early in-hospital temperature management protocol for heat stroke patients in people with Heat Stroke, run by Second Affiliated Hospital, Zhejiang University, School of Medicine at 7 sites in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Heat stroke is a life-threatening clinical syndrome characterized by an imbalance between heat production and heat dissipation in the body, resulting from exposure to hot and humid environments and/or strenuous exercise. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Heat Stroke
What is being tested?
the early in-hospital temperature management protocol for heat stroke patients
Could I receive a placebo?
No, everyone receives an active treatment
How many people
188 participants
Where
7 sitesChina
Study dates
1 Jul 2024to 30 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients admitted to the emergency department and diagnosed with heat stroke according to the China expert consensus on Heat Stroke

Who cannot join

  • transferred from another hospital and body temperature < 39.5℃; discharged within 4 hours, and subsequent body temperature or outcomes were unavailable; required immediate cardiopulmonary resuscitation; had other serious diseases, such as massive cerebral haemorrhage or severe trauma.

Trial locations and contacts

7 sites in 1 country. Contact the study team or a site near you to ask about taking part.

7 sites in 1 country

China7 sites, 7 recruiting
  • Dongyang People's Hospital

    Dongyang

    Shuying Xu

    Recruiting
  • Yongkang No.1 People's Hospital

    Guli, Zhejiang, 321300

    Huimin Ma, 86-0579-7111834, ykmhm@qq.com

    Recruiting
  • The Second Affiliated Hospital of Zhejiang University School of Medicine

    Hanzhou

    Xiuqin Feng, PRO, +86 13757119151, fengxiuqin@zju.edu.cn

    Lan Chen, M.Med., +86 13819987120

    Recruiting
  • Jinhua Municipal Central Hospital

    Jinhua

    Sunying Wu

    Recruiting
  • Jinhua People's Hospital

    Jinhua

    Liyun Lu, 779676709@qq.com

    Recruiting
  • Lanxi People's Hospital

    Lanxi

    Xiaoling Yang

    Recruiting
  • Yiwu Central Hospital

    Yiwu

    Zhumei Gong, 179219712@qq.com

    Recruiting

Other trials in China

About this study

Heat stroke is a life-threatening clinical syndrome characterized by an imbalance between heat production and heat dissipation in the body, resulting from exposure to hot and humid environments and/or strenuous exercise. It is defined by an elevated core temperature exceeding 40°C and central nervous system abnormalities, accompanied by multi-organ dysfunction. The severity of cellular and tissue damage in heat stroke patients depends on the peak temperature reached and the duration of hyperthermia. Rapid reduction of core temperature can halt cellular damage, quickly reverse organ dysfunction, and improve patient outcomes. Therefore, early identification and rapid cooling are crucial to prevent irreversible damage and death in heat stroke patients. However, there is a lack of systematic and specific protocols to guide emergency medical staff in the standardized and effective management of body temperature in heat stroke patients. To address this, our research team previously developed an early in-hospital temperature management protocol for heat stroke patients based on the best available evidence, expert consultations, and expert panel meetings. This study aims to validate the feasibility and effectiveness of the protocol through clinical research, providing a basis for clinical practice.

Conditions
Heat Stroke
Being tested
the early in-hospital temperature management protocol for heat stroke patients
Medical subject headings
Heat Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • the early in-hospital temperature management protocol for heat stroke patientsOther

    The early in-hospital temperature management protocol for heat stroke includes early identification, selection of cooling methods for rapid cooling, precise target temperature management, and dynamic monitoring. Effective temperature management will be implemented for heat stroke patients to improve their outcomes.

Study groups in NCT06537557
Study groupRoleWhat they receive
experimental groupExperimentalUsing the early in-hospital temperature management protocol for heat stroke patients developed in our previous research, we will implement early identification, rapid cooling, and precise target temperature management for this group of patients.
Receives: Other: the early in-hospital temperature management protocol for heat stroke patients
control groupNo interventionWe will retrospectively collect data on heat stroke patients who were visited before the implementation of the early in-hospital temperature management protocol between 2021 and 2022, meaning this group of patients received temperature management according to the original methods used by their respective hospitals.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. cooling rate at 0.5 hours

    The cooling rate at 0.5 hours was calculated in reference to initial body temperature and body temperature at 0.5 hours

    Measured: 0.5 hours

  2. Body temperature at 0.5 hours

    Body temperature at 0.5 hour refers to a reading obtained 25 to 35 minutes after admission.

    Measured: 0.5 hours

Secondary outcomes (4)
  1. Body temperature at 2 hours

    Body temperature at 2 hours refers to a reading taken 100 to 140 minutes after admission

    Measured: 2 hours

  2. in-hospital mortality

    Mortality from any cause during hospitalization

    Measured: 30 days

  3. 3-month mortality rate

    death within 3 months after emergency visit

    Measured: 3 months

  4. Number of participants with other complications

    including heart failure, renal failure, coagulation disorders, respiratory failure, neurological sequelae, etc.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Aug 2024
  2. Study start1 Jul 2024
  3. Primary completion30 Sep 2026 (estimated)
  4. Study completion30 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Sequential
Masking
None (open label)
Enrolment
188 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06537557
Sponsor's protocol ID
2024-0511
Status last verified
May 2026
First submitted
28 Jun 2024
Last updated
27 May 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing the early in-hospital temperature management protocol for heat stroke patients in people with Heat Stroke, run by Second Affiliated Hospital, Zhejiang University, School of Medicine at 7 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 27 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 7 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Xiuqin Feng (13757119151, fengxiuqin@zju.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

cooling rate at 0.5 hours (time frame: 0.5 hours). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in